HealthLynked (HLYKD) delays Q3 2025 10-Q filing under Form 12b-25

HealthLynked Corp. filed a Form 12b-25 to notify investors that it will be late in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.

Rhea-AI Filing Summary

HealthLynked Corp. filed a Form 12b-25 to notify investors that it will be late in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. The company states that it could not complete the Form 10-Q on time without unreasonable effort or expense because it needs additional time to finalize the financial statements for the report. HealthLynked anticipates filing the Form 10-Q within the five-day grace period allowed under Rule 12b-25 of the Securities Exchange Act of 1934.

Insights

Equity disclosure analyst

HealthLynked reports a short filing delay for its Q3 2025 10-Q.

HealthLynked Corp. is using Form 12b-25 to disclose that its Form 10-Q for the quarter ended September 30, 2025 will be filed late. The company explains that it needs more time to finalize the financial statements, and indicates that filing on time would have required unreasonable effort or expense.

The company states that it anticipates submitting the Form 10-Q within the five-day grace period provided by Rule 12b-25 for quarterly reports. This suggests a procedural delay rather than a disclosed, specific operational or financial event in this notice.

The notification itself does not quantify results or describe changes in operations, so the impact depends on the contents of the upcoming Form 10-Q once filed. This filing primarily serves to keep the company in compliance with reporting rules while it completes its quarterly report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did HealthLynked Corp. (HLYKD) file a Form 12b-25?

HealthLynked Corp. filed a Form 12b-25 to notify that its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 will be filed late because it needs additional time to finalize the financial statements.

Which report is delayed for HealthLynked Corp. (HLYKD)?

The delayed report is HealthLynked Corp.s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.

How long does HealthLynked expect the 10-Q filing delay to last?

HealthLynked states that it anticipates filing its Form 10-Q within the five-day grace period provided by Rule 12b-25 for quarterly reports.

What reason did HealthLynked give for the late Form 10-Q filing?

The company explains that it could not complete the Form 10-Q within the prescribed time without unreasonable effort or expense because it needs more time to finalize the financial statements included in the report.

Does HealthLynkeds Form 12b-25 provide financial results for Q3 2025?

No. The Form 12b-25 only explains the delay in filing the Q3 2025 Form 10-Q and the reason for that delay; it does not present quarterly financial results.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 11:36 AM Learn about SEC filing dates

SEC File Number

000-55768

CUSIP

42228P 300

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

For Period Ended: September 30, 2025

☐	Transition Report on Form 10-K
☐	Transition Report on Form 20-F
☐	Transition Report on Form 11-K
☐	Transition Report on Form 10-Q

For the Transition Period Ended: _________________________________________________

Read Instructions (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

HealthLynked Corp.

Full Name of Registrant

 N/A

Former Name if Applicable

1265 Creekside Parkway, Suite 200

Address of Principal Executive Office (Street and Number)

Naples, FL 34108

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

	(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed)

HealthLynked Corp., a Nevada corporation (the “Company”), is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (the “Form 10-Q”).

The Company could not complete the filing of its Form 10-Q within the prescribed time period without unreasonable effort or expense because additional time is needed to finalize the financial statements to be included in such report. The Registrant anticipates that it will file its Form 10-Q within the five-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended.

PART IV — OTHER INFORMATION

(1)	Name and telephone number of person to contact in regard to this notification
	Jeremy Daniel		(800)		928-7144
	(Name)		(Area Code)		(Telephone Number)
(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
Yes					☒	No		☐
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes					☐	No		☒
	If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

2

HealthLynked Corp.
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	November 17, 2025	By:	/s/ Jeremy Daniel
			Jeremy Daniel Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

3